OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ACLT55

Advanced Chemical Industries Plc

Consumer Goods ConglomeratesVerified

Advanced Chemical Industries Plc exhibits a highly leveraged capital structure, with a debt-to-equity ratio of 9.02, indicating a significant reliance on debt financing. The company's liquidity position is weak, as evidenced by a current ratio of 0.73, and its operating cash flow is negative at -6.77 billion BDT, suggesting challenges in generating sufficient cash from operations to meet short-term obligations. Profitability metrics are concerning, with a net loss of 483.89 million BDT and a negative return on equity of -6.42%, far below the typical performance of companies in the Consumer Goods Conglomerates industry. The operating margin is also weak, with operating income of 1.75 billion BDT on total revenue of 32.04 billion BDT, translating to a margin of 5.47%, which is likely below the industry median. The company's revenue is not segmented by product or geographic region in the available data, making it difficult to assess the concentration of risk or growth potential in specific markets or product lines. However, the negative free cash flow of -79.13 million BDT and capital expenditures of -2.43 billion BDT suggest that the company is investing in its operations, albeit without generating positive cash flow to support these investments. Looking ahead, the company's financial outlook is uncertain, with no specific guidance provided for the current or next fiscal year. The negative net income and operating cash flow indicate a need for strategic improvements to restore profitability and liquidity. The risk assessment highlights a medium liquidity risk and a low dilution risk, but the negative net cash position after subtracting total debt is a key flag that requires attention. Recent financial filings and transcripts do not provide additional insights into the company's strategic direction or operational performance, as the available data is limited to the financial snapshot and valuation metrics. The company's performance and risk profile suggest a need for a comprehensive review of its business model and capital structure to address the current financial challenges.

30-day price · ACLT(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyAdvanced Chemical Industries Plc
TickerACLT.DH
SectorConsumer Non-Cyclicals
BusinessConsumer Goods Conglomerates
Industry groupConsumer Goods Conglomerates
IndustryConsumer Goods Conglomerates
AI analysis

Business. Advanced Chemical Industries Plc operates in the Consumer Non-Cyclicals sector, specifically in the Consumer Goods Conglomerates industry, and generates revenue through a diversified portfolio of consumer goods products.

Classification. The company is classified under the industry of Consumer Goods Conglomerates within the Consumer Non-Cyclicals economic sector, with a confidence level of 0.92.

Advanced Chemical Industries Plc exhibits a highly leveraged capital structure, with a debt-to-equity ratio of 9.02, indicating a significant reliance on debt financing. The company's liquidity position is weak, as evidenced by a current ratio of 0.73, and its operating cash flow is negative at -6.77 billion BDT, suggesting challenges in generating sufficient cash from operations to meet short-term obligations. Profitability metrics are concerning, with a net loss of 483.89 million BDT and a negative return on equity of -6.42%, far below the typical performance of companies in the Consumer Goods Conglomerates industry. The operating margin is also weak, with operating income of 1.75 billion BDT on total revenue of 32.04 billion BDT, translating to a margin of 5.47%, which is likely below the industry median. The company's revenue is not segmented by product or geographic region in the available data, making it difficult to assess the concentration of risk or growth potential in specific markets or product lines. However, the negative free cash flow of -79.13 million BDT and capital expenditures of -2.43 billion BDT suggest that the company is investing in its operations, albeit without generating positive cash flow to support these investments. Looking ahead, the company's financial outlook is uncertain, with no specific guidance provided for the current or next fiscal year. The negative net income and operating cash flow indicate a need for strategic improvements to restore profitability and liquidity. The risk assessment highlights a medium liquidity risk and a low dilution risk, but the negative net cash position after subtracting total debt is a key flag that requires attention. Recent financial filings and transcripts do not provide additional insights into the company's strategic direction or operational performance, as the available data is limited to the financial snapshot and valuation metrics. The company's performance and risk profile suggest a need for a comprehensive review of its business model and capital structure to address the current financial challenges.
Key takeaways
  • Advanced Chemical Industries Plc is highly leveraged with a debt-to-equity ratio of 9.02, indicating a significant reliance on debt financing.
  • The company is currently unprofitable, with a net loss of 483.89 million BDT and a negative return on equity of -6.42%.
  • Liquidity is a concern, as evidenced by a current ratio of 0.73 and a negative operating cash flow of -6.77 billion BDT.
  • The company's capital expenditures of -2.43 billion BDT suggest ongoing investment, but without positive cash flow to support these investments.
  • The risk assessment highlights a medium liquidity risk and a low dilution risk, but the negative net cash position after subtracting total debt is a key flag.
  • # RATIONALES
  • ```json
  • {
Financial snapshot
PeriodHA-latest
CurrencyBDT
Revenue$32.04B
Gross profit$7.46B
Operating income$1.75B
Net income-$483.9M
R&D
SG&A
D&A
SBC
Operating cash flow-$6.77B
CapEx-$2.43B
Free cash flow-$791.3M
Total assets$97.44B
Total liabilities$89.90B
Total equity$7.54B
Cash & equivalents
Long-term debt$68.07B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$80.75B$5.56B$347.2M-$414.4M
FY-3$96.57B$6.43B$379.6M-$169.8M
FY-2$115.36B$6.14B-$494.0M-$3.03B
FY-1$124.32B$7.12B-$1.39B-$3.84B
FY0$137.90B$10.61B-$650.3M-$1.98B
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$72.10B$10.26B
FY-3$75.62B$10.30B
FY-2$90.91B$8.66B
FY-1$94.09B$6.97B
FY0$103.99B$8.05B
PeriodOCFCapExFCFSBC
FY-4-$1.88B-$1.93B-$414.4M
FY-3$307.7M-$2.20B-$169.8M
FY-2-$1.87B-$4.23B-$3.03B
FY-1$62.4M-$3.94B-$3.84B
FY0-$4.54B-$3.28B-$1.98B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$32.04B$1.75B-$483.9M-$791.3M
FQ-6$30.52B$2.07B$11.3M
FQ-5$31.35B$1.43B-$764.2M-$214.3M
FQ-4$29.71B$2.17B-$423.6M-$1.16B
FQ-3$36.49B$3.02B-$278.5M-$59.1M
FQ-2$35.74B$2.76B-$98.0M-$544.1M
FQ-1$35.97B$2.66B$149.8M-$210.0M
FQ0$36.96B$3.19B$34.1M-$144.1M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$97.44B$7.54B
FQ-6$97.05B$7.65B
FQ-5$94.09B$6.97B
FQ-4$98.04B$6.48B
FQ-3$104.42B$6.00B
FQ-2$104.88B$5.90B
FQ-1$103.99B$8.05B
FQ0$109.09B$8.19B
PeriodOCFCapExFCFSBC
FQ-7-$6.77B-$2.43B-$791.3M
FQ-6-$4.48B-$3.10B
FQ-5$62.4M-$3.94B-$214.3M
FQ-4-$4.74B-$869.6M-$1.16B
FQ-3-$5.59B-$1.48B-$59.1M
FQ-2-$7.30B-$2.21B-$544.1M
FQ-1-$4.54B-$3.28B-$210.0M
FQ0-$3.57B-$429.8M-$144.1M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$7.54B
Net cash-$68.07B
Current ratio0.7
Debt/Equity9.0
ROA-0.5%
ROE-6.4%
Cash conversion14.0%
CapEx/Revenue-7.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Consumer Goods Conglomerates · cohort 55 companies
MetricACLTActivity
Op margin5.5%8.7% medp25 5.5% · p75 14.8%bottom quartile
Net margin-1.5%3.8% medp25 0.2% · p75 10.3%bottom quartile
Gross margin23.3%23.6% medp25 17.7% · p75 31.3%below median
R&D / revenue1.9% medp25 1.9% · p75 1.9%
CapEx / revenue-7.6%-4.3% medp25 -6.1% · p75 -2.4%bottom quartile
Debt / equity902.0%62.8% medp25 20.6% · p75 131.5%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-15 23:30 UTC#1c996b46
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 06:21 UTCJob: 43831c5f